The Latest Breaking News from TMO

Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.

Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?

Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.

Sale 27-10 Gloucester: The hosts kickstarted the new Gallagher Prem season with a bonus-point win

Les Bleues face the Red Roses in the last four this weekend

Thermo Fisher Scientific has lagged behind the Dow Jones Industrial over the past year, but analysts maintain a strong bullish outlook on its future performance.

Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strategic acquisitions and robust growth potential. William Blair initiated coverage on Tuesday on Thermo Fisher Scientific, citing a strong…

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

While Thermo Fisher Scientific has underperformed the broader market over the past year, Wall Street analysts continue to hold a bullish view of the stock’s long-term prospects.